1vfh Citations

Structural evidence that alanine racemase from a D-cycloserine-producing microorganism exhibits resistance to its own product.

J Biol Chem 279 46153-61 (2004)
Related entries: 1vfs, 1vft

Cited: 25 times
EuropePMC logo PMID: 15302886

Abstract

Alanine racemase (ALR), an enzyme that catalyzes the interconversion of Ala enantiomers, is essential for the synthesis of the bacterial cell wall. We have shown that it is harder to inhibit the catalytic activity of ALR from D-cycloserine (DCS)-producing Streptomyces lavendulae than that from Escherichia coli by DCS. To obtain structural evidence for the fact that Streptomyces ALR displays resistance to DCS, we determined the precise nature of the x-ray crystal structures of the cycloserine-free and cycloserine enantiomer-bound forms of Streptomyces ALR at high resolutions. Streptomyces ALR takes a dimer structure, which is formed by interactions between the N-terminal domain of one monomer with the C-terminal domain of its partner. Each of the two active sites of ALR, which is generated as a result of the formation of the dimer structure, is composed of pyridoxal 5'-phosphate (PLP), the PLP-binding residue Lys(38), and the amino acids in the immediate environment of the pyridoxal cofactor. The current model suggests that each active site of Streptomyces ALR maintains a larger space and takes a more rigid conformation than that of Bacillus stearothermophilus ALR determined previously. Furthermore, we show that Streptomyces ALR results in a slow conversion to a final form of a pyridoxal derivative arising from either isomer of cycloserine, which inhibits the catalytic activity noncompetitively. In fact, the slow conversion is confirmed by the fact that each enzyme bound cycloserine derivative, which is bound to PLP, takes an asymmetric structure.

Articles - 1vfh mentioned but not cited (5)

  1. Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames). Couñago RM, Davlieva M, Strych U, Hill RE, Krause KL. BMC Struct Biol 9 53 (2009)
  2. The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. Im H, Sharpe ML, Strych U, Davlieva M, Krause KL. BMC Microbiol 11 116 (2011)
  3. Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane. De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C, Daviet L, Giros B. J Biol Chem 290 17848-17862 (2015)
  4. Crystallization and preliminary X-ray study of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Dong H, Xu S, Lu X, He G, Zhao R, Chen S, Fu S, Ju J. Acta Crystallogr Sect F Struct Biol Cryst Commun 69 660-662 (2013)
  5. Structure of the d-Cycloserine-Resistant Variant D322N of Alanine Racemase from Mycobacterium tuberculosis. de Chiara C, Prosser GA, Ogrodowicz R, de Carvalho LPS. ACS Bio Med Chem Au 3 233-239 (2023)


Reviews citing this publication (5)

  1. Structure, function and dynamics in the mur family of bacterial cell wall ligases. Smith CA. J Mol Biol 362 640-655 (2006)
  2. Resistance to antibiotics targeted to the bacterial cell wall. Nikolaidis I, Favini-Stabile S, Dessen A. Protein Sci 23 243-259 (2014)
  3. Biogenesis of D-amino acid containing peptides/proteins: where, when and how? Ollivaux C, Soyez D, Toullec JY. J Pept Sci 20 595-612 (2014)
  4. Targeted antibiotic discovery through biosynthesis-associated resistance determinants: target directed genome mining. O'Neill EC, Schorn M, Larson CB, Millán-Aguiñaga N. Crit Rev Microbiol 45 255-277 (2019)
  5. Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes. Sugiyama M. J Antibiot (Tokyo) 68 543-550 (2015)

Articles citing this publication (15)

  1. Andrimid producers encode an acetyl-CoA carboxyltransferase subunit resistant to the action of the antibiotic. Liu X, Fortin PD, Walsh CT. Proc Natl Acad Sci U S A 105 13321-13326 (2008)
  2. Inhibition of the PLP-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a novel decarboxylative mechanism of inactivation. Lowther J, Yard BA, Johnson KA, Carter LG, Bhat VT, Raman MC, Clarke DJ, Ramakers B, McMahon SA, Naismith JH, Campopiano DJ. Mol Biosyst 6 1682-1693 (2010)
  3. Residues Asp164 and Glu165 at the substrate entryway function potently in substrate orientation of alanine racemase from E. coli: Enzymatic characterization with crystal structure analysis. Wu D, Hu T, Zhang L, Chen J, Du J, Ding J, Jiang H, Shen X. Protein Sci 17 1066-1076 (2008)
  4. Characterization of endogenous pyridoxal 5'-phosphate-dependent alanine racemase from Bacillus pseudofirmus OF4. Ju J, Xu S, Wen J, Li G, Ohnishi K, Xue Y, Ma Y. J Biosci Bioeng 107 225-229 (2009)
  5. Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones. Lee Y, Mootien S, Shoen C, Destefano M, Cirillo P, Asojo OA, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG. Biochem Pharmacol 86 222-230 (2013)
  6. Cloning of alanine racemase genes from Pseudomonas fluorescens strains and oligomerization states of gene products expressed in Escherichia coli. Ju J, Yokoigawa K, Misono H, Ohnishi K. J Biosci Bioeng 100 409-417 (2005)
  7. D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategies. Omotade TO, Heffron JD, Klimko CP, Marchand CL, Miller LL, Halasahoris SA, Bozue JA, Welkos SL, Cote CK. J Appl Microbiol 115 1343-1356 (2013)
  8. Correlation between catalytic activity and monomer-dimer equilibrium of bacterial alanine racemases. Ju J, Xu S, Furukawa Y, Zhang Y, Misono H, Minamino T, Namba K, Zhao B, Ohnishi K. J Biochem 149 83-89 (2011)
  9. D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition. de Chiara C, Homšak M, Prosser GA, Douglas HL, Garza-Garcia A, Kelly G, Purkiss AG, Tate EW, de Carvalho LPS. Nat Chem Biol 16 686-694 (2020)
  10. Crystal structures of lysine-preferred racemases, the non-antibiotic selectable markers for transgenic plants. Wu HM, Kuan YC, Chu CH, Hsu WH, Wang WC. PLoS One 7 e48301 (2012)
  11. Structure-based function analysis of putative conserved proteins with isomerase activity from Haemophilus influenzae. Shahbaaz M, Ahmad F, Hassan MI. 3 Biotech 5 741-763 (2015)
  12. Identification and elucidation of in vivo function of two alanine racemases from Pseudomonas putida KT2440. Duque E, Daddaoua A, Cordero BF, De la Torre J, Antonia Molina-Henares M, Ramos JL. Environ Microbiol Rep 9 581-588 (2017)
  13. Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done? Seddon JA, Weld ED, Schaaf HS, Garcia-Prats AJ, Kim S, Hesseling AC. Int J Tuberc Lung Dis 22 24-33 (2018)
  14. Characterization and preliminary mutation analysis of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Xue Z, Hu Y, Xu S, Ohnishi K, Ma Y, Ju J, Zhao B. Extremophiles 17 611-621 (2013)
  15. News Conformational change of organic cofactor PLP is essential for catalysis in PLP-dependent enzymes. Ngo HP, Nguyen DQ, Park H, Park YS, Kwak K, Kim T, Lee JH, Cho KS, Kang LW. BMB Rep 55 439-446 (2022)


Related citations provided by authors (1)